|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
17
|
|
pubmed:dateCreated |
2002-5-24
|
|
pubmed:abstractText |
Although standard dose interferon (IFN) is successful in only 5% of patients with compensated hepatitis C virus (HCV)-related cirrhosis, it has been suggested that this therapy might decrease the risk of complications or the incidence of hepatocellular carcinoma. Based on HCV kinetics, daily IFN may improve response rates.
|
|
pubmed:language |
spa
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0025-7753
|
|
pubmed:author |
pubmed-author:BarreraJosep MariaJM,
pubmed-author:BoadasJaumeJ,
pubmed-author:BrugueraMiquelM,
pubmed-author:CasanovasTeresaT,
pubmed-author:DalmauBlaiB,
pubmed-author:DurándezRosaR,
pubmed-author:EnríquezJaimeJ,
pubmed-author:PlanasRamonR,
pubmed-author:QuerJuan CarlosJC,
pubmed-author:RichartCristóbalC,
pubmed-author:SolàRicartR,
pubmed-author:TorresMiquelM,
pubmed-author:ViverJosep MariaJM
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
11
|
|
pubmed:volume |
118
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
641-4
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
[Induction therapy with interferon alfa-2a in compensated hepatitis C virus-related cirrhosis. Randomized, multicenter study].
|
|
pubmed:affiliation |
Hospital Universitari Germans Trias i Pujol. Badalona. BArcelona. Spain. rplanas@ns.hugtip.scs.es
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Randomized Controlled Trial,
Multicenter Study
|
